Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 7/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.50 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.42 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7947849 | 0.81 | SLC6A2 (0.46) | SLC6A4SLC6A3SLC6A2DDB1CRBN | |
| SCHEMBL5635317 | 0.81 | SLC6A4 (0.47) | SLC6A4SLC6A3SLC6A2DDB1CRBN | |
| SCHEMBL2657671 | 0.78 | CRBN (0.47) | DDB1CRBNMAOAMAOBALDH1A1 | |
| SCHEMBL4467299 | 0.77 | DDB1 (0.47) | SLC6A4SLC6A3SLC6A2DDB1CRBN | |
| SCHEMBL2795867 | 0.73 | CYP1A2 (0.49) | SLC6A4SLC6A3SLC6A2DDB1CRBN | |
| SCHEMBL5223258 | 0.72 | DDB1 (0.43) | SLC6A4SLC6A3SLC6A2DDB1CRBN | |
| SCHEMBL29695938 | 0.72 | MAOA (0.58) | DDB1CRBNMAOAMAOBALDH1A1 | |
| Hydrochloric Acid SCHEMBL7476351 | 0.72 | CYP1A2 (0.47) | SLC6A4SLC6A3SLC6A2DDB1CRBN | |
| Hydrochloric Acid SCHEMBL1165090 | 0.72 | CA2 (0.39) | DDB1CRBNALDH1A1POLBMAPT | |
| SCHEMBL7940536 | 0.71 | SLC6A3 (0.50) | SLC6A4SLC6A3SLC6A2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6258827-B1 | HYDROXYAROMATIC HETEROCYCLIC ALKANOLS AND LEVODOPA | PFIZER INC. | 2001-07-10 | — | — | US | disclosed |
| US-6046213-A | Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydroxyphenyl)-2-(piperidinyl-1)-alkanol derivatives | PFIZER INC. (US) | 2000-04-04 | — | — | US | disclosed |
| EP-0828513-A2 | COMBINATIONS FOR THE TREATMENT OF PARKINSONISM CONTAINING SELECTIVE NMDA ANTAGONISTS | PFIZER INC. (US) | 1998-03-18 | — | — | EP | disclosed |
| EP-0777652-A1 | NEUROPROTECTIVE 3-(PIPERIDINYL-1)-CHROMAN-4,7-DIOL AND 1-(4-HYDROPHENYL)-2-(PIPERIDINYL-1)-ALKANOL DERIVATIVES | PFIZER INC. (US) | 1997-06-11 | — | — | EP | disclosed |
| WO-1996037226-A2 | COMBINATIONS FOR THE TREATMENT OF PARKINSONISM CONTAINING SELECTIVE NMDA ANTAGONISTS | PFIZER INC. (US) | 1996-11-28 | — | — | WO | disclosed |
| US-5498610-A | Neuroprotective indolone and related derivatives | PFIZER INC. (US) | 1996-03-12 | — | — | US | disclosed |
| WO-1996006081-A1 | NEUROPROTECTIVE 3-(PIPERIDINYL-1)-CHROMAN-4,7-DIOL AND 1-(4-HYDROPHENYL)-2-(PIPERIDINYL-1)-ALKANOL DERIVATIVES | PFIZER INC. (US) | 1996-02-29 | — | — | WO | disclosed |
| US-5306723-A | Neuroprotective indolone and related derivatives | PFIZER INC. (US) | 1994-04-26 | — | — | US | disclosed |
| EP-0554247-A1 | NEUROPROTECTIVE INDOLONE AND RELATED DERIVATIVES | PFIZER INC. (US) | 1993-08-11 | — | — | EP | disclosed |
| WO-1991017156-A1 | NEUROPROTECTIVE INDOLONE AND RELATED DERIVATIVES | PFIZER INC (US) | 1991-11-14 | — | — | WO | disclosed |